deltatrials
Completed NCT01456962

Influence of Antiretroviral Regimen on Immune Reconstitution in the Female Genital Tract

Influence of Raltegravir-Containing Antiretroviral Therapy (ART) on Immune Reconstitution and Activation in the Female Genital Tract

Sponsor: University of Colorado, Denver

Conditions Genital Diseases, Female HIV Infection Women's Health
Updated 11 times since 2017 Last updated: May 8, 2017 Started: Oct 31, 2011 Primary completion: Aug 31, 2013 Completion: Aug 31, 2013

This observational or N/A phase trial investigates Genital Diseases, Female and HIV Infection and is currently completed. University of Colorado, Denver leads this study, which shows 11 recorded versions since 2011 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Change History

11 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Dec 2021 — Jul 2024 [monthly]

    Completed

  4. Jan 2021 — Dec 2021 [monthly]

    Completed

  5. Nov 2020 — Jan 2021 [monthly]

    Completed

▶ Show 6 earlier versions

  1. Jun 2018 — Nov 2020 [monthly]

    Completed

  2. May 2018 — Jun 2018 [monthly]

    Completed

  3. Apr 2018 — May 2018 [monthly]

    Completed

    Phase: NA → None

  4. Aug 2017 — Apr 2018 [monthly]

    Completed NA

  5. Jul 2017 — Aug 2017 [monthly]

    Completed NA

  6. Jan 2017 — Jul 2017 [monthly]

    Completed NA

    First recorded

Oct 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Colorado, Denver
Data source: University of Colorado, Denver

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Aurora, United States